Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.

Abstract

Neonatal diabetes mellitus is rare, may either be transient or permanent, and may be caused by mutations in any of the several different genes. Until recently, most forms of permanent neonatal diabetes required lifelong subcutaneous insulin for management; however, permanent neonatal diabetes due to activating mutations in the KCNJ11 gene, which encodes the… (More)
DOI: 10.1111/j.1399-5448.2007.00316.x

Topics

Cite this paper

@article{Bremer2008OutpatientTO, title={Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.}, author={Andrew A. Bremer and Sayali A Ranadive and Robert H. Lustig}, journal={Pediatric diabetes}, year={2008}, volume={9 3 Pt 1}, pages={236-9} }